产品信息
| 产品号 | 商品名 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 参比药物(RLD) | 生物等效参考标准(RS) | 治疗等效代码 | 该申请号批准日期 | 该产品号批准日期 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|
| 001 | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG;2.5MG;1000MG | No | No | None | 2024/03/06 | -- | None (Tentative Approval) |
| 002 | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG;5MG;1000MG | No | No | None | -- | None (Tentative Approval) | |
| 003 | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 12.5MG;2.5MG;1000MG | No | No | None | -- | None (Tentative Approval) | |
| 004 | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 25MG;5MG;1000MG | No | No | None | -- | None (Tentative Approval) |